Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Schizophrenia Satellite symposium Article Cognitive impairment, as a key symptom of schizophrenia Schizophrenia Bipolar Article Debate continues on impact of duration of untreated psychosis on outcomes in psychosis Depression Anxiety Article Depressed or anxious? Depression Parkinson's Disease Article Depression in Parkinson’s disease